Xenetic Biosciences to acquire Santersus AG
Xenetic Biosciences announced a share exchange agreement to acquire Santersus AG with a company name change expected. The transaction highlights a strategic business combination for both entities.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day